MK-2118
MK-2118 is a GMP-synthesized STING agonist with the potential to inhibit advanced/metastatic solid tumors or lymphomas.[1].
Product Specifications
CAS Number
2218504-06-2
UNSPSC
12352005
Target
STING
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mk-2118.html
Smiles
COC1=CC(SC(C(C[C@@H](C(O)=O)C)=O)=C2)=C2C=C1OC
Molecular Formula
C15H16O5S
Molecular Weight
308.35
References & Citations
[1]Lyons T W, Thaisrivongs D A, Kuhl N, et al. The First GMP Synthesis of MK-2118, a Small Molecule Agonist for Stimulator of Interferon Genes[J]. Organic Process Research & Development, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP320445M 100 µg
Liver Carboxylesterase 1 (CES1) (NM_001025195) Human Recombinant Protein
Sign In for Pricing
View Details 
AN302117L-01 50 µL
Recombinant Histone H3 (Mono Methyl Arg2) Monoclonal Antibody
Sign In for Pricing
View Details